Lumos receives largest FebriDx order to date
Filed with ASX · · 2 pages · English
Watch Lumos Diagnostics' latest callLumos Diagnostics Holdings (ASX:LDX) Q3 2026 Earnings Call · Replay · Apr 20Read the transcript of Lumos Diagnostics Holdings (ASX:LDX) Q3 2026 Earnings CallLumos Diagnostics Holdings Ltd. on 6ix
Story so far
Earlier from Lumos Diagnostics
- Investor Presentation
- Lumos completes $20m placement and launches SPP
- US FDA Grants CLIA Waiver for FebriDx
- Trading Halt
- Lumos Delivers Several Pivotal Milestones in 1H FY26
Later from Lumos Diagnostics
- Lumos secures new contract manufacturing agreement
- Prospectus
- Response to ASX Aware Letter
- FebriDx Paediatric Study Enrolment Milestone Achieved
- FebriDx U.S. Rollout and Reimbursement Update
Follow Lumos Diagnostics into a list and get an email when it puts out news.
Follow Lumos Diagnostics